Q&A with Georgios Grammatikos, MD: Mass Spectrometry as Lipid ID'ing Method of The Future

Video

Georgios Grammatikos, MD, commented at The International Liver Congress 2015 in Vienna, Austria, "We do think in liver diseases we show the opening of this topic in chronic hepatopathy and we do believe mass spectrometric methods -- in order to identify the levels of single lipids-- as one method of the future."

Georgios Grammatikos, MD, commented at The International Liver Congress 2015 in Vienna, Austria, "We do think in liver diseases we show the opening of this topic in chronic hepatopathy and we do believe mass spectrometric methods -- in order to identify the levels of single lipids-- as one method of the future."

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.